BAMCO Inc’s Johnson & Johnson JNJ Stock Holding History

BAMCO Inc’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.39M	Buy	25,172 +2,672	+12%	+$623K	0.01%	255
2026 Q1	$5.5M	Buy	22,500 +18,900	+525%	+$4.4M	0.02%	245
2025 Q4	$745K	Buy	+3,600	New	+$712K	﹤0.01%	302

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BAMCO Inc's JNJ Position: Q2 2026 in Review

BAMCO Inc increased its Johnson & Johnson (JNJ) stake by 12% in Q2 2026, buying an estimated $623K and bringing the position to 25,172 shares worth $6.39M. The position accounts for 0.01% of the portfolio, ranked #255.

BAMCO Inc first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

BAMCO Inc held 25,172 shares of Johnson & Johnson worth $6.39M as of Q2 2026.
BAMCO Inc bought 2,672 Johnson & Johnson shares in Q2 2026, an estimated $623K.
Johnson & Johnson made up 0.01% of BAMCO Inc's portfolio in Q2 2026, its #255 holding.
BAMCO Inc first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.